Cell Free Bacteriophage Synthesis from Engineered Strains Improves Yield.
Rani BrooksLisa MoriciNicholas R SandovalPublished in: ACS synthetic biology (2023)
Phage therapy to treat life-threatening drug-resistant infections has been hampered by technical challenges in phage production. Cell-free bacteriophage synthesis (CFBS) can overcome the limitations of standard phage production methods by manufacturing phage virions in vitro. CFBS mimics intracellular phage assembly using transcription/translation machinery (TXTL) harvested from bacterial lysates and combined with reagents to synthesize proteins encoded by a phage genomic DNA template. These systems may enable rapid phage production and engineering to accelerate phages from bench-to-bedside. TXTL harvested from wild type or commonly used bacterial strains was not optimized for bacteriophage production. Here, we demonstrate that TXTL from genetically modified E. coli BL21 can be used to enhance phage T7 yields in vitro by CFBS. Expression of 18 E. coli BL21 genes was manipulated by inducible CRISPR interference (CRISPRi) mediated by nuclease deficient Cas12a from F. novicida (d Fn Cas12a) to identify genes implicated in T7 propagation as positive or negative effectors. Genes shown to have a significant effect were overexpressed (positive effectors) or repressed (negative effectors) to modify the genetic background of TXTL harvested for CFBS. Phage T7 CFBS yields were improved by up to 10-fold in vitro through overexpression of translation initiation factor IF-3 ( infC ) and small RNAs OxyS and CyaR and by repression of RecC subunit exonuclease RecBCD. Continued improvement of CFBS will mitigate phage manufacturing bottlenecks and lower hurdles to widespread adoption of phage therapy.
Keyphrases
- pseudomonas aeruginosa
- cell free
- drug resistant
- genome wide
- escherichia coli
- crispr cas
- circulating tumor
- acinetobacter baumannii
- cystic fibrosis
- transcription factor
- multidrug resistant
- stem cells
- genome editing
- wild type
- cell proliferation
- high resolution
- mass spectrometry
- gene expression
- copy number
- bone marrow
- replacement therapy